VijaySankarIyerMDPhD FACC FSCAI

Adult Congenital Heart Disease, Interventional Cardiology

Asociate Professor, Medicine, University at Buffalo SUNY School of Medicine & Biomedical Sciences Director , Cardiology Kaleida Health Director Structural Heart Interventions Director Interventional Cardiology Fellowship

Join to view full profile

Dr. Iyer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Iyer's full profile

Already have an account?

Office
1080 Youngs Rd
Amherst, NY 14051
Phone+1 716-882-6544

Summary

I am a board certified Interventional Cardiologist. I lead a very busy structural heart program. I currently perform more than 200 PCI's a year, > 250 TAVR, > 90 Mitraclio orocedures, >50 ASD/PFO. I also dirext an Interventional Cardiology Fellowsip.

Education & Training

University of MinnesotaFellowship, Interventional Cardiology, 2008 - 2009
University at BuffaloFellowship, Cardiovascular Disease, 2003 - 2006
University at BuffaloResidency, Internal Medicine, 2001 - 2002
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1999 - 2001
Grant Medical CollegeClass of 1995

Certifications & Licensure

NY State Medical License 2002 - 2026
MN State Medical License 2008 - 2017
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

FSCAI SCAI, 2010
Fellow (FACC) American College of Cardiology

Clinical Trials

Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD) Start of enrollment: 2016 Sep 01
Active, not recruiting
Not Applicable
PARTNER 3 Trial: Safety and Effectiveness of the SAPIEN 3 Transcatheter Heart Valve in Low Risk Patients With Aortic Stenosis Start of enrollment: 2016 Mar 01
Active, not recruiting
Not Applicable
REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System Start of enrollment: 2016 Sep 07
Terminated
Not Applicable

Publications & Presentations

PubMed

167 citations
Unloading the Left Ventricle Before Reperfusion in Patients With Anterior ST-Segment–Elevation Myocardial Infarction
Navin K. Kapur, Mohamad Adnan Alkhouli, Tony DeMartini, Haroon Faraz, Zachary H. George
Circulation. 2019-01-15
17 citations
Clinical Outcomes after Transcatheter Aortic Valve Replacement in Cancer Survivors Treated with Ionizing Radiation
Nikhil Agrawal, Sharma Kattel, Sameer Waheed, Ankita Kapoor, Vasvi Singh
Cardio-Oncology. 2019-07-22
2 citations
Left atrial appendage volume as a prognostic Indicator of long-term mortality in Cancer survivors treated with thoracic radiation.
Meer R Zafar, Ashutosh Sharma, Sunitha Shyam Sunder, Badri Karthikeyan, Makoto Nagahama
Cardio-Oncology. 2023-01-14

Authored Content

1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018
1-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients with Severe Mitral Annular CalcificationApril 2018

Press Mentions

Vivasure Medical Announces Enrollment of First Patients in Pivotal PATCH StudyMay 2nd, 2023
CycleNation Riders Pushed Pedals to Raise Funds for StrokeDecember 1st, 2022
Dietary Guidelines and Minimally Invasive ProceduresJanuary 26th, 2022
Join now to see all